Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid

Mostrar otras versiones (1)

The coronavirus disease 2019 (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is in urgent need of therapeutic options. High-throughput screening (HTS) offers the research field an opportunity to rapidly identify such compounds. In this work, we have develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorshkov, Kirill, Chen, Catherine Z., de la Torre, Juan Carlos, Martinez-Sobrido, Luis, Moran, Thomas, Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444285/
https://www.ncbi.nlm.nih.gov/pubmed/32839774
http://dx.doi.org/10.1101/2020.08.20.258129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444285/
https://www.ncbi.nlm.nih.gov/pubmed/32839774
http://dx.doi.org/10.1101/2020.08.20.258129

Ejemplares similares